Atlas Trials

UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas

Clinical trial NCT00082017 · TERMINATED

Trial details

NCT number
NCT00082017
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, Large-Cell, Ki-1Lymphoma, T-Cell
Start date
2004-04-05
Primary completion
2011-09-27
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.